{
    "clinical_study": {
        "@rank": "147793", 
        "acronym": "SEXUTOX", 
        "arm_group": [
            {
                "arm_group_label": "Col 1", 
                "description": "Patient with uterus adenocarcinoma, treated by surgery, then surveillance without complementary treatment"
            }, 
            {
                "arm_group_label": "Col 2", 
                "description": "Patient with uterus adenocarcinoma, treated by surgery then adjuvant radiotherapy"
            }, 
            {
                "arm_group_label": "Col 3", 
                "description": "patient with uterus adenocarcinoma, treated by surgery then curietherapy of vaginal dome"
            }, 
            {
                "arm_group_label": "Endometrial 4", 
                "description": "patient with cervix carcinoma stage IA2 to IIB, treated by surgery only"
            }, 
            {
                "arm_group_label": "endometrial 5", 
                "description": "patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy"
            }, 
            {
                "arm_group_label": "endometrial 6", 
                "description": "patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy and radiotherapy"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate the toxicities of cervix and corpus uteri carcinomas treatment"
        }, 
        "brief_title": "Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Corpus Uteri Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Uterine Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients whose treatment is provided to Centre Oscar Lambret\n\n          -  With a corpus uteri adenocarcinoma, no metastatic, treated by:\n\n               -  Surgery and observation without complementary treatment or\n\n               -  Surgery and adjuvant radiotherapy or\n\n               -  Surgery and curietherapy of vaginal dome\n\n          -  With a cervix carcinoma, stade IA2 to IIB proximal, treated by :\n\n               -  External radiochemotherapy and curietherapy or\n\n               -  Only surgery or\n\n               -  Pre-surgical curietherapy and surgery\n\n          -  Age > 18 years"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women with a corpus uteri carcinoma, without metastasis."
            }
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01650987", 
            "org_study_id": "SEXUTOX"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "carcinoma", 
            "uterus", 
            "Not metastatic"
        ], 
        "lastchanged_date": "July 26, 2012", 
        "location": {
            "contact": {
                "email": "p-nickers@o-lambret.fr", 
                "last_name": "Philippe NICKERS, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Lille", 
                    "country": "France", 
                    "zip": "59020"
                }, 
                "name": "Centre Oscar Lambret"
            }, 
            "investigator": [
                {
                    "last_name": "Eric LARTIGAU, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bernard CASTELAIN, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Eric LEBLANC, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fabrice NARDUCCI, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Anne LESOIN, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Annick CHEVALIER-PLACE, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "6", 
        "official_title": "Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function", 
        "overall_contact": {
            "email": "p-nickers@o-lambret.fr", 
            "last_name": "Philippe NICKERS, PhD"
        }, 
        "overall_contact_backup": {
            "email": "y-vendel@o-lambret.fr", 
            "last_name": "VENDEL Yvette, CRA sponsor", 
            "phone": "03 20 29 59 40"
        }, 
        "overall_official": {
            "affiliation": "Oscar Lambret Center", 
            "last_name": "Philippe NICKERS, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: The Commission nationale de l\u2019informatique et des libert\u00e9s", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary", 
            "measure": "Toxicities including on sexual function", 
            "safety_issue": "No", 
            "time_frame": "up to 3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01650987"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Compare the various scales of toxicity", 
                "measure": "Compare the various scales of toxicity", 
                "safety_issue": "No", 
                "time_frame": "up to 3 years"
            }, 
            {
                "description": "According to a questionnaire and a personal discussion", 
                "measure": "Study the sexual behavior modifications", 
                "safety_issue": "No", 
                "time_frame": "up to 3 years"
            }, 
            {
                "description": "Specify the existence of a correlation between toxicities included modifications and sexual behavior modifications", 
                "measure": "Specify correlation modifications of sexual behavior", 
                "safety_issue": "No", 
                "time_frame": "up to 3 years"
            }
        ], 
        "source": "Centre Oscar Lambret", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Oscar Lambret", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2012"
    }
}